Vancouver, Canada.—New research suggests patients receiving higher intensity dosage regimens of opioids are more likely to experience adverse outcomes such as abuse, hospitalizations and overdoses—at least among those suffering from pain associated with hip or knee osteoarthritis.
Researchers from Regeneron Pharmaceuticals, of Tarrytown, N.Y.; STATinMED Research, of Plano, Texas; Teva Pharmaceutical Industries, of Frazer, Pa.; and Analgesic Solutions, of Wayland, Mass., collaborated